Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fish oil cuts heart failure – study

This article was originally published in The Tan Sheet

Executive Summary

Supplementation with a single daily low-dose fish oil capsule in patients with chronic heart failure resulted in modest but clinically meaningful reductions in mortality and cardiovascular hospitalization in a 6,975-patient randomized, double-blind trial presented at the annual congress of the European Society of Cardiology. In the Italian study, patients with chronic heart failure received 1 g/day of omega-3 polyunsaturated fatty acids - n-3 PUFA - in the form of eicosapentaenoic acid and docosahexaenoic acid or a placebo. Patients treated with the inexpensive n-3 PUFA had an adjusted nine percent relative risk reduction and suffered essentially no side-effects, according to Dr. Luigi Tavazzi, chair of the study's steering committee and cardiology professor at the University of Pavia, Italy. The same study also concluded rosuvastatin at 10 mg/day had no effect on mortality or hospital admission for cardiovascular events, suggesting that patients with chronic heart failure should not be started on statins





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts